Needs a location
Data Transparency, de-identification strategies, and platforms available for sharing data.
The idea of data transparency became a reality year 2013 onwards. Pharmaceutical companies were started to share their own company trial data, and enables that data to be combined with data from other pharmaceutical companies. Many Regulatory authorities now require clinical trial sponsors to make clinical trial data available. Data sharing from clinical trials can lead to better understand and faster development and approval of medicines for rare diseases.One of such initiatives led to launch of platform to share clinical trial data related to cancer studies and the platform is called as PDS (Project Data Sphere).Other platforms available are Yale Open Data Access (YODA) and ClinicalStudyDataRequest.com (CDSR). Data transparency in Pharmaceutical industry requires data de-identification to protect patient confidentiality and comply with legal governing laws. In order to put data for research and other purpose we need to first de-identify the clinical data.
Arun Raj Vidhyadharan, inVentiv Health
Sunil Mohan Jairath, inVentiv Health
RSVP and you will get an email with a link and info to the webinar.
Thu, Sep 21,[masked]:00 PM - 12:45 PM CDT
You can also dial in using your phone.
United States: +1 (571)[masked]
Remember to put yourself on mute!
And this link allows testing/downloading of the software if you havent already used GTM before.
Try a test session: http://link.gotomeeting.com/email-welcome